OpenAlex
PricingAboutJobs
Log inGet started
Work

Cancer nanomedicine: is targeting our target?

HTML

Year: 2016
Type: article
Source: Nature Reviews Materials
DOI: 10.1038/natrevmats.2016.69
Authors: Twan Lammers, Fabian Kiessling, Marianne Ashford, Wim Hennink, Daan Crommelin, Gert Storm
Institutions: Utrecht University, Universitätsklinikum Aachen, University of Twente, AstraZeneca (United Kingdom)
Language: English

Topic: Nanoparticle-Based Drug Delivery
Subfield: Biomaterials
Field: Materials Science
Domain: Physical Sciences
Keywords: cancer nanomedicine, drug delivery, targeted drug delivery, patient benefit, cancer therapy
SDG: Good health and well-being

Open Access status: green

Funders: Deutsche Forschungsgemeinschaft, H2020 European Research Council
Awards: G2844955175, Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies, G3621515815, G6610374903
OpenAlex ID: W2510123569
FWCI: 9.735
Cites: 5
Cited by: 242
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms